1.45
price down icon2.68%   -0.04
after-market After Hours: 1.45
loading
Enlivex Therapeutics Ltd stock is traded at $1.45, with a volume of 250.28K. It is down -2.68% in the last 24 hours and up +29.46% over the past month. Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
See More
Previous Close:
$1.49
Open:
$1.45
24h Volume:
250.28K
Relative Volume:
2.04
Market Cap:
$34.29M
Revenue:
-
Net Income/Loss:
$-22.29M
P/E Ratio:
-1.2288
EPS:
-1.18
Net Cash Flow:
$-17.12M
1W Performance:
+29.23%
1M Performance:
+29.46%
6M Performance:
+31.82%
1Y Performance:
+9.02%
1-Day Range:
Value
$1.41
$1.52
1-Week Range:
Value
$1.16
$1.6592
52-Week Range:
Value
$0.8101
$1.76

Enlivex Therapeutics Ltd Stock (ENLV) Company Profile

Name
Name
Enlivex Therapeutics Ltd
Name
Phone
-
Name
Address
-
Name
Employee
36
Name
Twitter
@EnlivexT
Name
Next Earnings Date
2024-09-09
Name
Latest SEC Filings
Name
ENLV's Discussions on Twitter

Compare ENLV with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ENLV
Enlivex Therapeutics Ltd
1.45 35.54M 0 -22.29M -17.12M -1.18
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 117.32B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 58.89B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 51.14B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
673.80 41.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.59B 3.81B -644.79M -669.77M -6.24

Enlivex Therapeutics Ltd Stock (ENLV) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-02-21 Reiterated H.C. Wainwright Buy

Enlivex Therapeutics Ltd Stock (ENLV) Latest News

pulisher
Aug 01, 2025

Real time scanner hits for Enlivex Therapeutics Ltd. explainedImmediate Entry Point Prediction Strategy - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

Should you wait for a breakout in Enlivex Therapeutics Ltd.Free Capital Growth With Controlled Risk Picks - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

Can Enlivex Therapeutics Ltd. rally from current levelsLow Risk High Confidence Watchlist Builder - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

Enlivex Therapeutics Ltd. Charts Flash Early Recovery SignalsLow Risk High Return Opportunities Identified - metal.it

Aug 01, 2025
pulisher
Aug 01, 2025

Enlivex Therapeutics’ (ENLV) Buy Rating Reiterated at D. Boral Capital - Defense World

Aug 01, 2025
pulisher
Aug 01, 2025

Will Enlivex Therapeutics Ltd. stock go up soonPrice Action Trading with Volume Confirmation - Newser

Aug 01, 2025
pulisher
Jul 31, 2025

Risk vs reward if holding onto Enlivex Therapeutics Ltd.Technical Chart Summary for Momentum Stocks - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

Enlivex Therapeutics Ltd. stock momentum explainedAI Driven Buy Alert Trade Blueprint Released - metal.it

Jul 31, 2025
pulisher
Jul 31, 2025

Is Enlivex Therapeutics Ltd. showing signs of accumulationFree Consistent Income Focused Trade List - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

What institutional investors are buying Enlivex Therapeutics Ltd. stockLow Risk Strategy With Low Risk - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

What indicators show strength in Enlivex Therapeutics Ltd.Real-Time Investment Signal Forecast with AI - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

Applying big data sentiment scoring on Enlivex Therapeutics Ltd.Daily Market Movers Screener with Filters - Newser

Jul 31, 2025
pulisher
Jul 30, 2025

How Enlivex Therapeutics Ltd. stock performs during market volatilityWeekly Entry Signal Based Forecast Tool - Newser

Jul 30, 2025
pulisher
Jul 30, 2025

Top Risks to Consider Before Buying Enlivex Therapeutics Ltd. StockFree Risk Controlled Short Term Trade Plans - Newser

Jul 30, 2025
pulisher
Jul 29, 2025

Enlivex Therapeutics (ENLV) Receives Continued Buy Rating with $13 Price Target | ENLV Stock News - GuruFocus

Jul 29, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 12:00:48 - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Enlivex Therapeutics (ENLV) Completes Key Trial Stage for Alloce - GuruFocus

Jul 28, 2025
pulisher
Jul 28, 2025

Enlivex Completes Key Phase II Trial Milestone for Knee Osteoarthritis Treatment - TipRanks

Jul 28, 2025
pulisher
Jul 28, 2025

Enlivex Reaffirms August 18, 2025 As Target Date For Announcemen - GuruFocus

Jul 28, 2025
pulisher
Jul 28, 2025

Enlivex Therapeutics Completes Follow-Up for Phase II Trial of Allocetra™ in Knee Osteoarthritis Patients - Quiver Quantitative

Jul 28, 2025
pulisher
Jul 28, 2025

Enlivex Reaffirms August 18, 2025 As Target Date For Announcement of Phase II Topline Data - The Manila Times

Jul 28, 2025
pulisher
Jul 28, 2025

Enlivex Phase II Trial Data for 134 Knee Osteoarthritis Patients Set for August 18 Reveal - Stock Titan

Jul 28, 2025
pulisher
Jul 28, 2025

Does Enlivex Therapeutics Ltd. stock perform well during market downturnsAchieve superior capital gains with smart trades - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How Enlivex Therapeutics Ltd. stock performs during market volatility Short-Term Stock Trend Forecast Guide - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Is Enlivex Therapeutics Ltd. stock overvalued or undervaluedInvest confidently with real-time data analysis - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Is it the right time to buy Enlivex Therapeutics Ltd. stockMaximize your gains with expert trading tips - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What is Enlivex Therapeutics Ltd. company’s growth strategyUncover the best stocks for explosive growth - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How many analysts rate Enlivex Therapeutics Ltd. as a “Buy”Strongest growth potential - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How Resilient Is Enlivex Therapeutics Ltd. Stock During Economic Downturns3x Growth Potential - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

What drives Enlivex Therapeutics Ltd. stock priceFree Stock Market Knowledge Sharing - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Enlivex Therapeutics Ltd. Stock Analysis and ForecastFree Stock Market Query - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What makes Enlivex Therapeutics Ltd. stock price move sharplyValue Pick Scanner - Newser

Jul 25, 2025
pulisher
Jul 23, 2025

Is Enlivex Therapeutics Ltd. a good long term investmentExceptional profit velocity - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Enlivex Therapeutics Ltd. stockExceptional market positioning - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Enlivex Therapeutics (ENLV) Receives Continued 'Buy' Rating from Analyst | ENLV Stock News - GuruFocus

Jul 22, 2025

Enlivex Therapeutics Ltd Stock (ENLV) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
Cap:     |  Volume (24h):